Results 181 to 190 of about 59,730,718 (209)

ROS/pH‐Responsive Phenylboronic Acid–Chitosan Nanoparticles Improve Silymarin‐Mediated Hepatoprotection After Hepatectomy With Gut‐Liver Axis‐Associated Responses

open access: yesAdvanced Science, EarlyView.
Bioactive phenylboronic acid–chitosan nanoparticles enable responsive silymarin delivery for post‐hepatectomy liver protection. The nanoplatform integrates antioxidant and antibacterial functions, improves hepatic recovery, and is associated with coordinated shifts in gut microbiota, metabolites, cytokines, and hepatic proteomic pathways, suggesting a ...
Jinjin Tong   +9 more
wiley   +1 more source

The Deubiquitinase UCHL1 Drives Susceptibility to Atrial Fibrillation by Stabilizing CaMKII‐δ

open access: yesAdvanced Science, EarlyView.
UCHL1 is highly upregulated in mice and patients with AF. UCHL1 directly binds to and removes K48‐linked polyubiquitin chains from CaMKII‐δ at K251 and enhances CaMKII‐δ stability, which activates RyR2, disrupts Ca2+ handling, and promotes AF. These findings establish UCHL1 as a critical regulator of CaMKII‐δ stability and AF‐related Ca2+ handling ...
Hai‐Lian Bi   +6 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis

Molecular Biology Reports, 2016
Rheumatoid arthritis (RA) is an inflammatory disorder of the joints that affects 0.5-1 % of adults. Excessive growth of the fibroblast-like synoviocytes (FLS) promotes hyperplasia of synovial tissues and causes its invasion into the bone and cartilage, which eventually causes deformity and dysfunction of affected joints.
Yunxia, Li   +7 more
openaire   +2 more sources

Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease

Cytokine, 2015
The aim of the study was to characterize and to quantify peripheral and tissue. IL-35- and IL-37-producing cells in Inflammatory Bowel Disease (IBD) patients. We studied a total of 38 active UC, 31 inactive UC, 17 active CD, and 13 inactive CD and 50 non-inflamed tissues as control group.
Gabriela, Fonseca-Camarillo   +2 more
openaire   +2 more sources

The Protective Effect of Esculentoside A on MPL/lpr Mice by Upregulating the Expression of CD19+IL-35+Breg Cells and Interleukin-35

International Archives of Allergy and Immunology
Introduction: Esculentoside A (EsA) is one of the main components of the traditional Chinese medicine Phytolacca esculenta. The possible mechanism of action of EsA in the treatment of lupus nephritis (LN) was explored by observing the effects of EsA on CD19+ IL-35+regulatory B (IL-35+Breg) cells.
Xing, Wang   +3 more
openaire   +2 more sources

Interleukins in Cancer: From Biology to Therapy

Nature Reviews Cancer, 2021
Peter Libby   +2 more
exaly  

Interleukin-35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters and IL-35 levels: the mexican genetics of atherosclerotic disease (GEA) study

Atherosclerosis, 2017
Rosalinda Posadas-Sánchez   +7 more
openaire   +1 more source

EVALUATION OF INTERLEUKIN-35 (IL — 35) LEVEL IN SERUM OF PSORIATIC PATIENTS

The Arab Journal of Laboratory Medicine
RABIE BEDEIR ATA ALLAH   +6 more
openaire   +1 more source

Interleukin-35 (IL-35) and Interleukin-39 (IL-39) in Rheumatoid Arthritis: Relation to Disease Activity

Egyptian Journal of Medical Microbiology
Sahar A. Mouhran   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy